No-reflow phenomenon and prognosis in patients with acute myocardial infarction (Q36577567)

15 August 2017

1 reference

title

No-reflow phenomenon and prognosis in patients with acute myocardial infarction (English)

1 reference

15 August 2017

myocardial infarction

1 reference

Hiroshi Ito

1

1 reference

15 August 2017

1 September 2006

1 reference

Nature Clinical Practice Cardiovascular Medicine

15 August 2017

1 reference

15 August 2017

3

1 reference

15 August 2017

499-506

1 reference

15 August 2017

9

1 reference

Recognition of the importance of embolization in atherosclerotic vascular disease

15 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0632

Lack of myocardial perfusion immediately after successful thrombolysis. A predictor of poor recovery of left ventricular function in anterior myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0632

Characterization of spatial patterns of flow within the reperfused myocardium by myocardial contrast echocardiography. Implications in determining extent of myocardial salvage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0632

Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. GUSTO-I Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0632

Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0632

Clinical implications of the 'no reflow' phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0632

7 January 2021

The "no-reflow" phenomenon after temporary coronary occlusion in the dog.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0632

7 January 2021

Ultrastructural evidence of microvascular damage and myocardial cell injury after coronary artery occlusion: which comes first?

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0632

7 January 2021

Progressive decreases in coronary vein flow during reperfusion in acute myocardial infarction: clinical documentation of the no reflow phenomenon after successful thrombolysis

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0632

7 January 2021

Are we mortgaging the medical profession?

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0632

7 January 2021

Predictive factors for development of the no-reflow phenomenon in patients with reperfused anterior wall acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0632

7 January 2021

Noninvasive prediction of ultimate infarct size at the time of acute coronary occlusion based on the extent and magnitude of collateral-derived myocardial blood flow

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0632

7 January 2021

Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0632

7 January 2021

Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Inf

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0632

7 January 2021

No-reflow phenomenon and lesion morphology in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0632

7 January 2021

Plaque gruel of atheromatous coronary lesion may contribute to the no-reflow phenomenon in patients with acute coronary syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0632

7 January 2021

Detection of embolic particles with the Doppler guide wire during coronary intervention in patients with acute myocardial infarction: efficacy of distal protection device.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0632

7 January 2021

Myocardial contrast echocardiography with a new calibration method can estimate myocardial viability in patients with myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0632

7 January 2021

A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0632

7 January 2021

Myocardial perfusion patterns related to thrombolysis in myocardial infarction perfusion grades after coronary angioplasty in patients with acute anterior wall myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0632

7 January 2021

Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent Primary Angioplasty in Myocardial Infarction Study Group

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0632

7 January 2021

Alternation in the coronary blood flow velocity pattern in patients with no reflow and reperfused acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0632

7 January 2021

Relation of phasic coronary flow velocity characteristics with TIMI perfusion grade and myocardial recovery after primary percutaneous transluminal coronary angioplasty and rescue stenting

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0632

7 January 2021

Two different coronary blood flow velocity patterns in thrombolysis in myocardial infarction flow grade 2 in acute myocardial infarction: insight into mechanisms of microvascular dysfunction.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0632

7 January 2021

A comparison of electrocardiographic changes during reperfusion of acute myocardial infarction by thrombolysis or percutaneous transluminal coronary angioplasty

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0632

7 January 2021

Determinants and prognostic implications of persistent ST-segment elevation after primary angioplasty for acute myocardial infarction: importance of microvascular reperfusion injury on clinical outcome

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0632

7 January 2021

Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0632

7 January 2021

Detection of acutely impaired microvascular reperfusion after infarct angioplasty with magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0632

7 January 2021

Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0632

7 January 2021

Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0632

7 January 2021

Effects of glycoprotein IIb/IIIa inhibition on microvascular flow after coronary reperfusion. A quantitative myocardial contrast echocardiography study

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0632

7 January 2021

Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0632

7 January 2021

Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0632

7 January 2021

Randomized evaluation of the effects of filter-based distal protection on myocardial perfusion and infarct size after primary percutaneous catheter intervention in myocardial infarction with and without ST-segment elevation.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0632

7 January 2021

Distal protection improved reperfusion and reduced left ventricular dysfunction in patients with acute myocardial infarction who had angioscopically defined ruptured plaque.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0632

7 January 2021

Efficacy of rheolytic thrombectomy in early versus late myocardial infarction.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0632

7 January 2021

Postconditioning: a form of "modified reperfusion" protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0632

7 January 2021

Postconditioning the human heart

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0632

7 January 2021

Beneficial effects of intracoronary adenosine as an adjunct to primary angioplasty in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0632

7 January 2021

A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II).

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0632

7 January 2021

Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with reperfused anterior wall myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0632

7 January 2021

Impact of a single intravenous administration of nicorandil before reperfusion in patients with ST-segment-elevation myocardial infarction.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0632

7 January 2021

Beneficial effect of intracoronary verapamil on microvascular and myocardial salvage in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0632

7 January 2021

The effect of verapamil on the restoration of myocardial perfusion and functional recovery in patients with angiographic no-reflow after primary percutaneous coronary intervention.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0632

7 January 2021

Effects of the nitric oxide donor nitroprusside on no-reflow phenomenon during coronary interventions for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0632

7 January 2021

Myocardial cell protection : a challenging time for action and a challenging time for clinical research

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0632

7 January 2021

Inhibition of the sodium-hydrogen exchanger with cariporide to prevent myocardial infarction in high-risk ischemic situations. Main results of the GUARDIAN trial. Guard during ischemia against necrosis (GUARDIAN) Investigators

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0632

7 January 2021

The Na(+)/H(+) exchange inhibitor eniporide as an adjunct to early reperfusion therapy for acute myocardial infarction. Results of the evaluation of the safety and cardioprotective effects of eniporide in acute myocardial infarction (ESCAMI) trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0632

7 January 2021

Phosphatidylinositol-3-kinase signaling is required for erythropoietin-mediated acute protection against myocardial ischemia/reperfusion injury

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0632

7 January 2021

Identifiers

DOI

10.1038/NCPCARDIO0632

1 reference

15 August 2017

1 reference

PubMed ID

16932767